生物谷
(920266)
| 流通市值：0.00万 | | | 总市值：0.00万 |
| 流通股本：0.00万 | | | 总股本：0.00万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 207,571,938.26 | 92,118,348.63 | 516,232,107.07 | 420,136,311.75 |
| 营业收入 | 207,571,938.26 | 92,118,348.63 | 516,232,107.07 | 420,136,311.75 |
| 二、营业总成本 | 238,588,994.29 | 109,835,302.62 | 537,883,852.27 | 413,228,498.54 |
| 营业成本 | 87,077,703.61 | 44,564,931.5 | 139,940,745.88 | 99,270,136.57 |
| 税金及附加 | 4,127,337.88 | 1,678,595.71 | 10,106,151.48 | 7,947,952.82 |
| 销售费用 | 102,108,716.69 | 41,948,563.62 | 280,722,395.7 | 249,985,366.04 |
| 管理费用 | 37,771,928.29 | 18,220,315.97 | 93,412,243.69 | 46,395,822.12 |
| 研发费用 | 6,680,191.47 | 3,106,530.71 | 13,188,627.91 | 9,208,001.89 |
| 财务费用 | 823,116.35 | 316,365.11 | 513,687.61 | 421,219.1 |
| 其中:利息费用 | 1,195,505.82 | 541,774.36 | 2,726,573.61 | 2,160,758.39 |
| 其中:利息收入 | 383,518.89 | 233,517.96 | 2,233,095.29 | 1,755,030.05 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 677,990.39 | - | 837,201.82 | 124,026.71 |
| 加:投资收益 | 99,902.68 | 50,213.03 | 511,555.11 | 447,686.62 |
| 资产处置收益 | 739,105.08 | -2,093.73 | -2,238.68 | 79,592 |
| 资产减值损失(新) | 519,289.98 | -485,081.64 | -1,234,550 | -632,544.81 |
| 信用减值损失(新) | -1,303,511.28 | -368,158.34 | -61,301,650.4 | -8,657,613.09 |
| 其他收益 | 3,611,093.42 | 2,280,056.12 | 7,242,168.73 | 4,822,791.26 |
| 四、营业利润 | -26,673,185.76 | -16,242,018.55 | -75,599,258.62 | 3,091,751.9 |
| 加:营业外收入 | 274.06 | 274.05 | 196,730.58 | 0.32 |
| 减:营业外支出 | 292,782.89 | 50,183.75 | 2,037,173.01 | 337,319.18 |
| 五、利润总额 | -26,965,694.59 | -16,291,928.25 | -77,439,701.05 | 2,754,433.04 |
| 减:所得税费用 | 1,379,831.55 | 476,275.58 | -3,038,736.14 | 963,916.76 |
| 六、净利润 | -28,345,526.14 | -16,768,203.83 | -74,400,964.91 | 1,790,516.28 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -28,345,526.14 | -16,768,203.83 | -74,400,964.91 | 1,790,516.28 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -28,345,526.14 | -16,768,203.83 | -74,400,964.91 | 1,790,516.28 |
| 扣除非经常损益后的净利润 | -32,455,771.47 | -18,704,729.69 | -80,214,736.92 | -2,575,744.79 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.23 | -0.14 | -0.6 | 0.01 |
| (二)稀释每股收益 | -0.23 | - | -0.6 | 0.01 |
| 九、综合收益总额 | -28,345,526.14 | -16,768,203.83 | -74,400,964.91 | 1,790,516.28 |
| 归属于母公司股东的综合收益总额 | -28,345,526.14 | - | -74,400,964.91 | 1,790,516.28 |
| 公告日期 | 2025-08-21 | 2025-04-29 | 2025-04-29 | 2024-10-29 |
| 审计意见(境内) | | | 保留意见 | |